The effect of acids on the survival of HIV during drug injection

Journal of Acquired Immune Deficiency Syndromes

Volumn 45, Issue 2, 2007, Pages 144-150

  Heimer, Robert ^a   Kinzly, Mark L ^a   He, Helen ^a   Abdala, Nadia ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Citric acid; Harm reduction; HIV transmission; Injection drug use; Syringes

Indexed keywords

CITRIC ACID;

ACIDIFICATION; ACIDITY; ARTICLE; CONTROLLED STUDY; DRUG USE; HARM REDUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK REDUCTION; STATISTICAL MODEL; SYRINGE; VIRAL CONTAMINATION; VIRUS INFECTIVITY; VIRUS SURVIVAL; VIRUS TRANSMISSION; VIRUS VIABILITY;

CITRIC ACID; HIV INFECTIONS; HIV-1; HUMANS; HYDROGEN-ION CONCENTRATION; SOLUTIONS;

EID: 34249888757     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318042aede     Document Type: Article

References (39)

1. Newton-John HF, Wise K, Looke DF. Role of the lemon in disseminated candidiasis of heroin abusers. Med J Aust. 1984;140:780-781.
2. Scheidegger C, Pietrzak J, Frei R. Methadone diluted with contaminated orange juice or raspberry syrup as a potential source of disseminated candidiasis in drug abusers. Eur J Clin Microbiol Infect Dis. 1993;12:229-231.
3. Carnwath T, Smith I. Heroin Century. London: Routledge; 2002.
4. Strang J, Keaney F, Butterworth G, et al. Different forms of heroin and their relationship to cook-up techniques: data on, and explanation of, use of lemon juice and other acids. Subst Use Misuse. 2001;36:573-588.
5. Buchanan D, Tooze JA, Shaw S, et al. Demographic, HIV risk behavior, and health status characteristics of "crack" cocaine injectors compared to other injection drug users in three New England cities. Drug Alcohol Depend. 2006;81:221-229.
6. Carlson R, Falck R, Siegal H. Crack cocaine injection in the heartland: an ethnographic perspective. Med Anthropol. 2000;18:305-323.
7. Hunter GM, Donoghoe MC, Stimson GV. Crack use and injection on the increase among injecting drug users in London. Addiction. 1995;90:1397-1400.
8. Johnson WA, Ouellet LJ. The injection of crack cocaine among Chicago drug users. Am J Public Health. 1996;86:266.
9. Bisbe J, Miro JM, Latorre X, et al. Disseminated candidiasis in addicts who use brown heroin: report of 83 cases and review. Clin Infect Dis. 1992;15:910-923.
10. Cazorla C, Grenier de Cardenal D, Schuhmacher H, et al. Infectious complications and misuse of high-dose buprenorphine. Presse Med. 2005;34:719-724.
11. Pfefferkorn U, Viehl CT, Bassetti S, et al. Injection site abscesses in intravenous drug users. Frequency of associated complications related to localisation. Chirurg. 2005;76:1053-1057.
12. Rhodes T, Lowndes C, Judd A, et al. Explosive spread and high prevalence of HIV infection among injecting drug users in Togliatti City, Russia. AIDS. 2002;16:F25-F31.
13. Sergeyev B, Oparina T, Rumyantseva TP, et al. HIV prevention for drug injectors in Yaroslavl, Russia: a peer-driven intervention and needle exchange. J Drug Issues. 1999;29:777-804.
14. Heimer R, Booth RE, Irwin KS, et al. HIV and Drug Use in Eurasia. In: Twigg JL, ed. Basingstoke, Hampshire, UK: Palgrave Macmillan; 2006:141-163.
15. Ongradi J, Ceccherini-Nelli L, Pistello M, et al. Acid sensitivity of cellfree and cell-associated HIV-1: clinical implications. AIDS Res Hum Retroviruses. 1990;6:1433-1436.
16. Saltzman BR, Friedman-Kien AE. Inactivation of HIV and safety precautions for the workplace. Recent Results Cancer Res. 1988;112:75-83.
17. Tjotta E, Hungnes O, Grinde B. Survival of HIV-1 activity after disinfection, temperature and pH changes, or drying. J Med Virol. 1991;35:223-227.
18. Wallhäußer KH. Praxis der Sterilisation, Desinfektion, Konservierung - Keimidentifizierung, Betriebshygiene, vol. XXIV. Stuttgart, Germany: Georg Thieme Verlag; 1988.
19. Abdala N, Stephens PC, Griffith BP, et al. Survival of HIV-1 in syringes. J Acquir Immune Defic Syndr Hum Retrovirol. 1999;20:73-80.
20. Clatts MC, Heimer R, Abdala N, et al. HIV-1 transmission in injection paraphernalia: heating drug solutions may inactivate HIV-1. J Acquir Immune Defic Syndr. 1999;22:194-199.
21. Hollinger FB, Bremer JW, Myers LE, et al. Standardization of sensitive human immunodeficiency virus coculture procedures and establishment of a multicenter quality assurance program for the AIDS Clinical Trials Group. J Clin Microbiol. 1992;30:1787-1794.
22. Gaughwin MD, Gowans E, Ali R, et al. Bloody needles: the volumes of blood transferred in simulations of needlestick injuries and shared use of syringes for injection of intravenous drugs. AIDS. 1991;5:1025-1027.
23. Grund JP, Stern LS. Residual blood in syringes: size and type of syringe are important. AIDS. 1991;5:1532-1533.
24. Myers LE, McQuay LJ, Hollinger B. Dilution assay statistics. J Clin Microbiol. 1994;32:732-739.
25. Budavari S, ed. The Merck Index. 11th ed. Rahway, NJ: Merck & Co.; 1989.
26. Rook EJ, Huitema AD, van den Brink W, et al. Population pharmacokinetics of heroin and its major metabolites. Clin Pharmacokinet. 2006;45:401-417.
27. Connor RI. Sensitivity of non-clade B primary HIV-1 isolates to mildly acidic pH. J Acquir Immune Defic Syndr. 2006;43:499-501.
28. Dichtelmuller H, Rudnick D, Kloft M. Inactivation of lipid enveloped viruses by octanoic acid treatment of immunoglobulin solution. Biologicals. 2002;30:135-142.
29. Olmsted SS, Khanna KV, Ng EM, et al. Low pH immobilizes and kills human leukocytes and prevents transmission of cell-associated HIV in a mouse model. BMC Infect Dis. 2005;5:79.
30. Booth RE, Kennedy J, Brewster T, et al. Drug injectors and dealers in Odessa, Ukraine. J Psychoactive Drugs. 2003;35:419-426.
31. Grund JP, Kobzev D, Melnikov V, et al. Drug use patterns and HIV risk behaviors of Russian syringe exchange participants. Presented at: 12th International Conference on the Reduction of Drug-Related Harm; 2001; New Delhi.
32. Baranova MV, Borodkina OI, Girchenko PV, et al. Social and demographic characteristics of injecting drug users in Russia (the results of studies conducted in 11 Russian cities). Presented at: 13th International Conference on AIDS, Cancer and Public Health; 2005; St. Petersburg.
33. Grund JPC. A candle lit from both ends: the epidemic of HIV infection in Central and Eastern Europe. In: McElrath K, ed. HIVand AIDS: A Global View. Westport, CT: Greenwood Press; 2001:41-67.
34. de la Fuente L, Saavedra P, Barrio G, et al. Temporal and geographic variations in the characteristics of heroin seized in Spain and their relation with the route of administration. Spanish Group for the Study of the Purity of Seized Drugs. Drug Alcohol Depend. 1996;40:185-194.
35. Kozlov AP, Shaboltas AV, Toussova OV, et al. HIV incidence and factors associated with HIV acquisition among injection drug users in St. Petersburg, Russia. AIDS. 2006;20:901-906.
36. Peck JA, Shoptaw S, Rotheram-Fuller E, et al. HIV-associated medical, behavioral, and psychiatric characteristics of treatment-seeking, methamphetamine-dependent men who have sex with men. J Addict Dis. 2005;24:115-132.
37. Rhodes T, Platt L, Maximova S, et al. Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: a multi-city study. Addiction. 2006;101:252-266.
38. Morin SF, Steward WT, Charlebois ED, et al. Predicting HIV transmission risk among HIV-infected men who have sex with men: findings from the Healthy Living Project. J Acquir Immune Defic Syndr. 2005;40:226-235.
39. Hoffman PN, Larkin DP, Samuel D. Needlestick and needleshare - the difference. J Infect Dis. 1989;160:545-546.